Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000

ReutersReuters2026/07/20 23:20
By:Reuters
  • Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky sold 5,000 common shares on July 16, 2026 at USD 23.
  • Direct holdings fell to 401,288 shares following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001820885-26-000016), on July 20, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!